Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Cunningham T. J., Antemann R., Paonessa D., Sponzo R. W., Steiner D. Adjuvant immuno- and/or chemotherapy with neuraminidase-treated autogenous tumor vaccine and Bacillus Calmette-Guérin for head and neck cancers. Ann N Y Acad Sci. 1976;277(00):339–344. doi: 10.1111/j.1749-6632.1976.tb41712.x. [DOI] [PubMed] [Google Scholar]
- Currie G. A. Effect of active immunization with irradiated tumour cells on specific serum inhibitors of cell-mediated immunity in patients with disseminated cancer. Br J Cancer. 1973 Jul;28(1):25–35. doi: 10.1038/bjc.1973.67. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Currie G. A., Lejeune F., Fairley G. H. Immunization with irradiated tumour cells and specific lymphocyte cytotoxicity in malignant melanoma. Br Med J. 1971 May 8;2(5757):305–310. doi: 10.1136/bmj.2.5757.305. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Currie G. A., McElwain T. J. Active immunotherapy as an adjunct to chemotherapy in the treatment of disseminated malignant melanoma: a pilot study. Br J Cancer. 1975 Feb;31(2):143–156. doi: 10.1038/bjc.1975.19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Green A. A., Pratt C., Webster R. G., Smith K. Immunotherapy of osteosarcoma patients with virus-modified tumor cells. Ann N Y Acad Sci. 1976;277(00):396–411. doi: 10.1111/j.1749-6632.1976.tb41717.x. [DOI] [PubMed] [Google Scholar]
- Gutterman J. U., Mavligit G., Reed R., Richman S., McBride C. E., Hersh E. M. Immunology and immunotherapy of human-malignant melanoma: historic review and perspectives for the future. Semin Oncol. 1975 Jun;2(2):155–174. [PubMed] [Google Scholar]
- Hedley D. W., McElwain T. J., Currie G. A. Specific active immunotherapy does not prolong survival in surgically treated patients with stage IIB malignant melanoma and may promote early recurrence. Br J Cancer. 1978 Apr;37(4):491–496. doi: 10.1038/bjc.1978.76. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Holmes E. C., Eilber F. R., Morton D. L. Immunotherapy of malignancy in humans. Current status. JAMA. 1975 Jun 9;232(10):1052–1055. [PubMed] [Google Scholar]
- Rosato F. E. Active specific immunotherapy of human solid tumors. Ann N Y Acad Sci. 1976;277(00):332–338. doi: 10.1111/j.1749-6632.1976.tb41711.x. [DOI] [PubMed] [Google Scholar]
- Rosato F. E., Brown A. S., Miller E. E., Rosato E. F., Mullis W. F., Johnson J., Moskovitz A. Neuraminidase immunotherapy of tumors in man. Surg Gynecol Obstet. 1974 Nov;139(5):675–682. [PubMed] [Google Scholar]
- Rosato F. E., Miller E., Rosato E. F. Active specific immunotherapy of human solid tumors. Va Med. 1978 Mar;105(3):221–223. [PubMed] [Google Scholar]